European Union seals second Covid deal


As reported, Murashko said that the symptoms after being injected with the Russian COVID-19 vaccine "level off" by the next day and the complications are "described in the instructions and are predictable".

Peru's foreign ministry said on Saturday it managed to sign the binding agreement on Friday and will get access to 12 million doses of COVID-19 vaccines through COVAX, a scheme for pooled procurement and equitable distribution of eventual vaccines. Moreover, member states may donate reserved doses to lower and middle-income countries.

More than 170 countries have joined the global vaccine plan to help buy and distribute immuni-sation shots for Covid-19 fairly around the world, WHO director-general Tedros Adhanom Ghebreyesus said on Thursday.

"We will soon sign more similar agreements and put together a diverse range of possible vaccines based on different types of technologies", the European Union presidency Ursula von der Leyen said according to the press release.

The worldwide non-governmental organization Oxfam says a small group of wealthy nations has already bought up half of the future global supplies of coronavirus vaccines.

European Commissioner for Health Stella Kyriakides said this second agreement is yet another milestone in the EU's vaccine strategy, which is expanding possibilities to ensure that EU citizens and people around the world can gradually resume their daily life.

Apple Watch Series 6 puts an emphasis on tracking blood oxygen levels
This one comes in more simple colours, and starts at $429 but is also available with 4G connectivity. Williams was tapped to detail the company's new Apple Watch Series 6 and Apple Watch SE models.

The Sofia Globe's coverage of the Covid-19 situation in Bulgaria is supported by the Embassy of Switzerland.

To provide additional transparency in the context of the pandemic, the company also made Phase 3 protocol available online.

Together with the Member States and the European Medicines Agency, the Commission will use existing flexibilities to accelerate the authorisation and availability of successful vaccines against COVID-19.

There is now no internationally-approved vaccine for COVID-19, the illness caused by the new coronavirus, which has claimed more than 946,000 lives and derailed the world economy.

The Drugs Controller General of India (DCGI) had on September 11 directed the SII to suspend any new recruitment in the phase-II and III clinical trial of the vaccine till further orders after AstraZeneca paused the trials in other countries because of "an unexplained illness" in a participant in the study. No one will be safe until everyone is safe. Phase three studies will be launched by the end of 2020.